Form 4 for ELVN Enliven Therapeutics, Inc.

Accepted 2026-01-12 00:00:00 ET · period of report 2026-01-08 · accession 0001584759-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2026-01-12	2026-01-08+	ELVN	Heyman Richard A.	Dir	S - Sale	$25.02	-13.9K	25.5K	-35%	-$348.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-01-08	S	D	8,015	$25.04	29,392	I See footnote	—	—	(F4) This transaction was executed in multiple trades at prices ranging from $25.00 to $25.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F5) The shares are held of record by the Heyman Daigle Trust.
2	Common	Common Stock	2026-01-09	S	D	4,285	$25.00	25,107	I See footnote	—	—	(F6) This transaction was executed in multiple trades at prices ranging from $25.00 to $25.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F5) The shares are held of record by the Heyman Daigle Trust.
3	Common	Common Stock	2026-01-08	S	D	1,620	$25.00	25,545	I See footnote	—	—	(F2) The shares are held of record by RAHD Capital LLC.